Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
refined notoginseng root dry extract
- Development stage
- Unknown
- Lead developer
- Chengdu Huasen Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Refined notoginseng root dry extract is a standardized herbal preparation derived from the roots of *Panax notoginseng* (Burkill) F.H. Chen. Developed by the **HuaSun Group** with regulatory and scientific assistance from **SU BioMedicine**, this extract represents a significant milestone in the integration of Traditional Chinese Medicine (TCM) into Western regulatory frameworks. It was successfully included in the German Drug Codex (**DAC 2018**) and subsequently the German Pharmacopoeia (**DAB 2020**), establishing it as a pharmaceutical-grade substance in Europe. The extract is characterized by a high concentration of dammarane-type saponins, specifically notoginsenoside R1 and ginsenosides Rg1 and Rb1. These active constituents are recognized for their multi-target effects on the cardiovascular system, including anti-inflammatory, anti-oxidative, and anti-thrombotic activities, as well as the ability to improve microcirculation and provide neuroprotection.
- Other names
- Notoginseng radix extractum siccum raffinatumPanax notoginseng root dry extractRefined Notoginseng Root Extract
02
Targets
NOS2 (Nitric Oxide Synthase 2)NOS3 (eNOS)
Beyond the preview
Go deeper on refined notoginseng root dry extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on refined notoginseng root dry extract.